Symbiotec Pharmalab share news and announcements
NSE: SYMBIOTECBSE: 544889Pharmaceuticals & Biotechnology
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,197.50.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹7,481 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Sep 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,58,23231.5% delivered
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Symbiotec Pharmalab quarterly results
The board met on 21 Sep 2026 to consider financial results
Notice filed 11 Sep 2026
To consider and approve the financial results for the period ended Jun 30, 2026 (opens in a new tab)
Symbiotec Pharmalab annual reports, presentations and earnings calls
The company's own documents, latest first.
Investor presentations1
- Investor Presentation (opens in a new tab)21 Sep 2026
Earnings calls2
- Transcript (opens in a new tab)28 Sep 2026
- Link of Recording (opens in a new tab)22 Sep 2026
Symbiotec Pharmalab share news and announcements
13 announcements, routine notices left out, newest first.
Oct 2026
Sep 2026
21 Sep · Board meeting
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts).
- 22 Sep 2026Resultsdown 3.04%−2.8 pts vs Nifty 500market median −0.7% · five sessions −8.7% (−5.9 pts vs Nifty 500) · delivery +0.8 pts against usual · The announcement (opens in a new tab)
Symbiotec Pharmalab results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.